{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:21:03Z","timestamp":1789615263676,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Mendel.ai"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-68873-8","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T16:26:24Z","timestamp":1770135984000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2692-6306","authenticated-orcid":false,"given":"Ravi B.","family":"Parikh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likhitha","family":"Kolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Beothy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9966-1973","authenticated-orcid":false,"given":"William J.","family":"Ferrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Laventure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled Essam Mahmoud","family":"Dosoky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Tarabishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth S.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayana","family":"Andalcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Maloney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Ulises","family":"Mena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wael","family":"Salloum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ezekiel J.","family":"Emanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"68873_CR1","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/EDBK_156686","volume":"35","author":"JM Unger","year":"2016","unstructured":"Unger, J. M., Cook, E., Tai, E. & Bleyer, A. Role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am. Soc. Clin. Oncol. Educ. Book 35, 185\u2013198 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"68873_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11305-3","volume":"23","author":"JAC Duenas","year":"2023","unstructured":"Duenas, J. A. C., Sanchez, P. N. & Bonilla, C. E. Comparison of clinical outcomes among cancer patients treated in and out of clinical trials. BMC Cancer 23, 786 (2023).","journal-title":"BMC Cancer"},{"key":"68873_CR3","doi-asserted-by":"publisher","first-page":"dju002","DOI":"10.1093\/jnci\/dju002","volume":"106","author":"JM Unger","year":"2014","unstructured":"Unger, J. M. et al. Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J. Natl. Cancer Inst. 106, dju002 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"68873_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncr.23157","volume":"112","author":"JG Ford","year":"2008","unstructured":"Ford, J. G. et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112, 228\u2013242 (2008).","journal-title":"Cancer"},{"key":"68873_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/EDBK_156686","volume":"35","author":"JM Unger","year":"2016","unstructured":"Unger, J. M., Cook, E., Tai, E. & Bleyer, A. The role of clinical trial participation in cancer research: barriers, evidence, and strategies. Am. Soc. Clin. Oncol. Educ. Book 35, 185\u2013198 (2016).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"68873_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.ijmedinf.2019.05.018","volume":"129","author":"SM Meystre","year":"2019","unstructured":"Meystre, S. M., Heider, P. M., Kim, Y., Aruch, D. B. & Britten, C. D. Automatic trial eligibility surveillance based on unstructured clinical data. Int. J. Med. Inf. 129, 13\u201319 (2019).","journal-title":"Int. J. Med. Inf."},{"key":"68873_CR7","doi-asserted-by":"publisher","unstructured":"Keber, M., Grubi\u0161i\u0107, I., Bare\u0161i\u0107, A. & Jovi\u0107, A. A Review on Neuro-symbolic AI Improvements to Natural Language Processing. in 2024 47th MIPRO ICT and Electronics Convention (MIPRO) 66\u201372 https:\/\/doi.org\/10.1109\/MIPRO60963.2024.10569741(2024).","DOI":"10.1109\/MIPRO60963.2024.10569741"},{"key":"68873_CR8","first-page":"1265","volume":"15","author":"K Hamilton","year":"2024","unstructured":"Hamilton, K., Nayak, A., Bo\u017ei\u0107, B. & Longo, L. Is neuro-symbolic AI meeting its promises in natural language processing? A structured review. Semantic Web 15, 1265\u20131306 (2024).","journal-title":"Semantic Web"},{"key":"68873_CR9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/jamia\/ocab228","volume":"29","author":"B Idnay","year":"2021","unstructured":"Idnay, B., Dreisbach, C., Weng, C. & Schnall, R. A systematic review on natural language processing systems for eligibility prescreening in clinical research. J. Am. Med. Inf. Assoc. 29, 197\u2013206 (2021).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"68873_CR10","doi-asserted-by":"publisher","first-page":"e27767","DOI":"10.2196\/27767","volume":"9","author":"T Haddad","year":"2021","unstructured":"Haddad, T. et al. Accuracy of an artificial intelligence system for cancer clinical trial eligibility screening: retrospective pilot study. JMIR Med. Inf. 9, e27767 (2021).","journal-title":"JMIR Med. Inf."},{"key":"68873_CR11","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1093\/jamia\/ocae243","volume":"31","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review. J. Am. Med. Inf. Assoc. 31, 2749\u20132759 (2024).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"68873_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-77447-x","volume":"14","author":"K Lee","year":"2024","unstructured":"Lee, K. et al. CriteriaMapper: establishing the automatic identification of clinical trial cohorts from electronic health records by matching normalized eligibility criteria and patient clinical characteristics. Sci. Rep. 14, 25387 (2024).","journal-title":"Sci. Rep."},{"key":"68873_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-023-01916-6","volume":"23","author":"SM Meystre","year":"2023","unstructured":"Meystre, S. M. et al. Piloting an automated clinical trial eligibility surveillance and provider alert system based on artificial intelligence and standard data models. BMC Med. Res. Methodol. 23, 88 (2023).","journal-title":"BMC Med. Res. Methodol."},{"key":"68873_CR14","first-page":"1086","volume":"310","author":"NV Do","year":"2024","unstructured":"Do, N. V. et al. Matching patients to accelerate clinical trials (MPACT): enabling technology for oncology clinical trial workflow. Stud. Health Technol. Inf. 310, 1086\u20131090 (2024).","journal-title":"Stud. Health Technol. Inf."},{"key":"68873_CR15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.11613\/BM.2012.031","volume":"22","author":"ML McHugh","year":"2012","unstructured":"McHugh, M. L. Interrater reliability: the kappa statistic. Biochem. Med. 22, 276\u2013282 (2012).","journal-title":"Biochem. Med."},{"key":"68873_CR16","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1001\/jama.2019.18058","volume":"322","author":"RB Parikh","year":"2019","unstructured":"Parikh, R. B., Teeple, S. & Navathe, A. S. Addressing bias in artificial intelligence in health care. JAMA 322, 2377\u20132378 (2019).","journal-title":"JAMA"},{"key":"68873_CR17","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1002\/cncr.35307","volume":"130","author":"L Kolla","year":"2024","unstructured":"Kolla, L. & Parikh, R. B. Uses and limitations of artificial intelligence for oncology. Cancer 130, 2101\u20132107 (2024).","journal-title":"Cancer"},{"key":"68873_CR18","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1093\/jamia\/ocad118","volume":"30","author":"DY Wang","year":"2023","unstructured":"Wang, D. Y. et al. Artificial intelligence suppression as a strategy to mitigate artificial intelligence automation bias. J. Am. Med. Inf. Assoc. 30, 1684\u20131692 (2023).","journal-title":"J. Am. Med. Inf. Assoc."},{"key":"68873_CR19","first-page":"100066","volume":"2","author":"A Bashkirova","year":"2024","unstructured":"Bashkirova, A. & Krpan, D. Confirmation bias in AI-assisted decision-making: AI triage recommendations congruent with expert judgments increase psychologist trust and recommendation acceptance. Comput. Hum. Behav.: Artif. Hum. 2, 100066 (2024).","journal-title":"Comput. Hum. Behav.: Artif. Hum."},{"key":"68873_CR20","doi-asserted-by":"crossref","unstructured":"Agarwal, N., Moehring, A., Rajpurkar, P. & Salz, T. Combining Human Expertise with Artificial Intelligence: Experimental Evidence from Radiology. SSRN Scholarly Paper at https:\/\/papers.ssrn.com\/abstract=4505053 (2023).","DOI":"10.2139\/ssrn.4505053"},{"key":"68873_CR21","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/s41591-024-02850-w","volume":"30","author":"F Yu","year":"2024","unstructured":"Yu, F. et al. Heterogeneity and predictors of the effects of AI assistance on radiologists. Nat. Med 30, 837\u2013849 (2024).","journal-title":"Nat. Med"},{"key":"68873_CR22","unstructured":"Jin, Q. et al. Matching Patients to Clinical Trials with Large Language Models. ArXiv arXiv:2307.15051v5 (2024)."},{"key":"68873_CR23","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/asi.24007","volume":"69","author":"DZ Korman","year":"2018","unstructured":"Korman, D. Z., Mack, E., Jett, J. & Renear, A. H. Defining textual entailment. J. Assoc. Inf. Sci. Technol. 69, 763\u2013772 (2018).","journal-title":"J. Assoc. Inf. Sci. Technol."},{"key":"68873_CR24","unstructured":"M\u00fcndler, N., He, J., Jenko, S. & Vechev, M. Self-contradictory Hallucinations of Large Language Models: Evaluation, Detection and Mitigation. In International Conference on Learning Representations. Paper at https:\/\/openreview.net\/pdf?id=EmQSOi1X2f (2024)."},{"key":"68873_CR25","unstructured":"Wang B, Wang H, Tu XM, Feng C. Comparisons of Superiority, Non-inferiority, and Equivalence Trials. Shanghai Arch Psychiatry 29, 385\u2013388."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68873-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68873-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T14:09:38Z","timestamp":1773151778000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-68873-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["68873"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-68873-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ravi B. Parikh declares the following competing interests: grants from the National Institutes of Health, Department of Defense, Prostate Cancer Foundation, National Palliative Care Research Center, NCCN Foundation, Conquer Cancer Foundation, Humana, Emerson Collective, Schmidt Futures, Arnold Ventures, Mendel.ai, and Veterans Health Administration; personal fees and equity from GNS Healthcare, Thyme Care, Optinosis, Main Street Health, and Onc.AI; personal fees from the ConcertAI, Cancer Study Group, Mendel.ai, Biofourmis, Archetype Therapeutics, CreditSuisse, G1 Therapeutics, Humana, and Nanology; honoraria from Flatiron and Medscape; has board membership (unpaid) at the Coalition to Transform Advanced Care and American Cancer Society; editor at the Journal of Clinical Oncology; and serves on a leadership consortium (unpaid) at the National Quality Forum, all outside the submitted work. Ezekiel Emanuel declares the following competing interests: travel reimbursement from Centre for Biomedical Ethics, National University of Singapore; travel to Global Innovation Forum AAHC, Washington, DC; travel reimbursement from Macalester College, St. Paul, MN; travel reimbursement from Oak CEO Summit, honorarium from Advocate Aurora Health Summit, travel reimbursement from DPharm Conference, honorarium and travel reimbursement from the University of Pittsburgh Medical Center Shadyside, Pittsburgh, PA; travel reimbursement from the University of California San Francisco, San Francisco, CA; travel reimbursement from Cain Brothers Conference, New York, NY; honorarium and travel reimbursement from Bowdoin College, Brunswick, ME; travel reimbursement from The Galien Foundation, travel reimbursement from HLTH 2022 Meeting, Las Vegas, NV; travel reimbursement from the Hawaii Medical Service Association, Honolulu, HI; travel reimbursement from the Tel Aviv University, Tel Aviv, Israel; travel reimbursement from The Suntory Foundation, Tokyo, Japan; honorarium and travel reimbursement from the Ontario Hospital Association, Ontario, Canada; Monetary prize and travel reimbursement from the University of Oklahoma, Oklahoma City, OK; travel reimbursement from The Quadrangle, Haverford, PA; lodging Lazard HC Leadership Summit, Walland, TN; travel reimbursement from HLTH 2023 Meeting, Las Vegas, NV; honorarium and travel reimbursement from Sanford Health, Sioux Falls, SD; honorarium and travel reimbursement from Health Plan Alliance, Atlanta, GA; honorarium and travel reimbursement from Emory Health Care Leaders Retreat, Greensboro, GA; honorarium and travel reimbursement from Employer Direct Health Care, Aspen, CO; travel reimbursement from the University of Virginia, Roslyn, VA; travel reimbursement from the New York Historical Society, New York, NY; lodging Amangiri Executive Retreat, Canyon Point, UT; travel reimbursement from Forerunner Conference, Sao Paulo, Brazil; travel reimbursement from BCEPS conference, Solstrand, Norway; travel reimbursement Arendaluska Meeting, Arendal, Norway; lodging Futures of Science Summit, Philadelphia, PA; travel reimbursement from The Galien Foundation New York; travel reimbursement from the Milken Institute Washington, DC. Dr. Emanuel is serving on the following: Member Board of Advisors Cellares Corp.; Advisor Notable Health; Member Advisory Board JSL Health Capital; Member Advisory Board Peterson Center on Health Care; Advisor Clarify Health Solutions; Consultant Health Care Foundry Inc.; Member Advisory Board Feel Better Ltd.; Consultant Korro\/Coach AI Ltd.; Consultant Aberdeen Inc.; Member Board of Advisors Alto Pharmacy Holdings; Advisor Link Health Technologies; Advisor Nuna; Expert Advisory Member WHO COVID 19 Ethics & Governance Working Group; Advisory Board Member HIEX Health Innovation Exchange partnership sponsored by UN Geneva; Advisory Board Member Biden\u2019s Transition COVID-19 Committee; Special Advisor to the Director General World Health Organization; Editorial Board Member Journal of the American Medical Association; Member Guideline Development Group (GDG) of the WHO Rapid Advice Guideline on the Use & Indications of Glucagon-Like Peptide-1 Receptor Agonists for Management of Adults Living with Obesity; Member Internal Advisory Board The Penn Parity Center; Advisor Dendro Technologies Inc. (CalmiGo). Dr. Emanuel reports investments in Sunstone Consulting and Aktivate. Dr. Emanuel reports royalties from his books and William Morris Endeavor. Dr. Emanuel reports the following grants: Hogan Lovells, Mendel Health Inc., University of Bergen, Jansen Pharmaceuticals Inc., Schmidt Futures Schwab Charitable Fund, Laura and John Arnold Foundation, Humana, University of Miami, Hawaii Medical Services Association, Patient Centered Outcomes Research Institute. Dr. Emanuel reports options for Nuna, Link Health Technologies, Inc, Clarify Health Solutions, Healthcare Foundry Inc., Alto Pharmacy Holdings, Korro\/Coach AI Ltd., FeelBetter LTD., Notable Health, Cellares Corp., Sunstone Consulting; all outside the submitted work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2306"}}